Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Time Series Analysis For Leprosy in Tocantins

Ferreira KCCL, Santos AJFD, Gomes H, et al. RGSA- Revista de Gestao Social e Ambiental. Revista de Gestão Social e Ambiental. 2025; 19 (4) : 1-15.
Download PDF
Publication

Global trends and burdens of neglected tropical diseases and malaria from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021

Chen J, Tian X, Guo D, et al. Springer Science and Business Media LLC. BMC Public Health. 2025;
Download PDF
Publication

Unmasking the mimic: Leprosy neuropathy misdiagnosed as chronic inflammatory demyelinating polyneuropathy: A case report from Saudi Arabia

AlOtaibi MK, AlQahtani BG, AlQawahmed RM. Saudi Medical Journal. Neurosciences. 2025; 30 (2) : 5.
Download PDF
Publication

Global Trends in the Incidence, Prevalence and Disability-Adjusted Life Years of Leprosy from 1990 to 2019: An Age-Period-Cohort Analysis Using the Global Burden of Disease Study 2019

Zhang K, Zhang W, Lu H. Informa UK Limited. Clinical, Cosmetic and Investigational Dermatology. 2025;
Download PDF
Publication

AVALIAÇÃO DE PACIENTES COM HANSENÍASE EM UM ESTÁGIOS CURRICULAR E EXTRACURRICULAR NA ATENÇÃO BÁSICA: UM RELATO DE EXPERIÊNCIA

SILVA M, LEITE N, RODRIGUES M, et al. Revista Piauiense de Enfermagem. 2025;
Download PDF
Publication

Incidence and Clinical Patterns of Leprosy in Interior Sindh; Retrospective Study

Jaikishan , Gemnani V, Abro K, et al. Med Forum. 2025; 36 (1) : 6.
Download PDF
Publication

Leprosy elimination phase in Alagoas, 2001-2022: an ecological study

Lima LVD, Pavinati G, Silva RGTD, et al. FapUNIFESP (SciELO). Epidemiologia e Serviços de Saúde. 2025;
Download PDF
Publication

Unveiling lives: A glimpse into the daily routines of individuals affected by leprosy in Malaysia using the walk-and-talk technique

Abdul Rahman N, Rajaratnam V, Peters RMH, et al. Informa UK Limited. Global Public Health. 2025; 20 (1) : 16.
Download PDF
Publication

Neuroimaging in Leprosy: A Case Series Exploring Domains Beyond Peripheral Nerves

Elangovan K, Kumar S, Garg RK, et al. Springer Science and Business Media LLC. Cureus. 2025;
Download PDF
Publication

Borderline lepromatous leprosy with lymph node infiltration: Dermatology helps helping to clarify challenging diagnoses

Reis VHMD, Miola AC, Ferreira CAZ, et al. Elsevier BV. Anais Brasileiros de Dermatologia. 2025;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 28
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD